Table 2 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer

2026 Open access

Read full text
Authors: Takahiro Ohashi, Tsubasa Nagasaki, Kayoko Kawai-Asami, Kotomi Akatsuka, Yuko Nagata, Sayuri Terada, Shinsuke Hiramoto, Eika Higashi, Ryuichiro Ohshita, Mizuki Kuramochi, Makoto Furuya, Mai Todoroki
+2 more Hisashi Yoshimi, Keiko Fukushima
DOI: 10.1158/2767-9764.31429910
Cited by: 0

Abstract

Top 20 significantly upregulated and downregulated differentially expressed genes after treatment with ZSTK3744 compared with DMSO-treated cells.

Fields of Study & Subjects

Breast Cancer Treatment Studies Estrogen and related hormone effects Prostate Cancer Treatment and Research

Publication details

Publication date
27 February 2026
Language
EN